DERMATOLOGIC AND OPHTHALMIC DRUGS ADVISORY COMMITTEE
September 18-19, 2000
Slides
Accutane
September 19, 2000
Food and Drug Administration
Medication Guides, Nancy M Ostrove PhD
Drug-Induced Depression, Erick Turner, MD
Positive Rechallenge Cases of Accutane - Associated Depressive Symptoms, Marilyn R Pitts, PharmD
Hormonal Contraceptive Interaction Studies and New Formulation PK, E Dennis Bashaw, PharmD
Safety and Efficacy Comparison Trial, Kathryn O'Connell, MD, PhD
Hoffmann-La Roche Inc.
Introduction & Risk Management, Russell Ellison, MD, Roche Laboratories, Inc ppt html
Overview of Psychiatric Disorders & Clinical Analysis of Spontaneous Reports, Douglas Jacobs, MD, Harvard Medical School ppt html
Accutane-Psychiatric Disorders: A Pharmacoepidemiological Safety Assessment, Robert C Nelson, PhD, RCN Associates Inc ppt html
Psychiatric Conditions Attempts to Confirm Signal, John McLane, PhD, Roche Medical Science and Safety ppt html
A New Once-Daily Formulation of Isotretinoin Accutane NF, John McLane, PhD, Roche Medical Science and Safety & David Young, PharmD, PhD, GloboMax LLC ppt html
Accutane and Psychiatric Illness, Liam Grant, Roaccutane Action Group, Ireland ppt html